Results 91 to 100 of about 13,840,459 (217)

Treatment of neovascular age-related macular degeneration: Current therapies

open access: yesClinical Ophthalmology, 2009
Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe ...
Albert J Augustin   +2 more
doaj  

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients

open access: yesJournal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi   +8 more
doaj   +1 more source

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment

open access: yes, 2018
Pear Pongsachareonnont,1,2 Michael Ying Kit Mak,2 Cameron Paul Hurst,3 Wai-Ching Lam2,4 1Vitreo-Retinal Research Unit, Department of Ophthamology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross ...
Pongsachareonnont P   +3 more
core  

The prevalence rate of pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration.

open access: yes, 2016
The prevalence rate of pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration.
James Shaffer (2136346)   +2 more
core   +1 more source

Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMD

open access: yesClinical Ophthalmology, 2022
Jeffrey K Luttrull,1 Gerry Gray2 1Ventura County Retina Vitreous Medical Group, Ventura, CA, USA; 2Regulatory Pathways, Inc, Laguna Beach, CA, USACorrespondence: Jeffrey K Luttrull, Ventura County Retina Vitreous Medical Group, 3160 Telegraph Road, Suite
Luttrull JK, Gray G
doaj  

Association between pseudodrusen and incidence of the neovascular age-related macular degeneration (nAMD) in the fellow eye.

open access: yes, 2016
Association between pseudodrusen and incidence of the neovascular age-related macular degeneration (nAMD) in the fellow eye.
James Shaffer (2136346)   +2 more
core   +1 more source

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

open access: yesClinical Ophthalmology, 2013
Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y   +3 more
doaj  

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

open access: yesJournal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant   +7 more
doaj   +1 more source

Depression and anxiety in age-related macular degeneration

open access: yes, 2016
Eung Suk Kim,1 Yonguk Kim,1 Seung-Young Yu,1 Moosang Kim2 1Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University, Seoul, 2Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, Korea We ...
Yu SY, Kim ES, Kim Y, Kim M
core  

Prevalence, crude odds ratios (ORs), and 95% confidence intervals (CIs) for neovascular age-related macular degeneration among sampled subjects.

open access: yes, 2016
Prevalence, crude odds ratios (ORs), and 95% confidence intervals (CIs) for neovascular age-related macular degeneration among sampled subjects.
Herng-Ching Lin (284636)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy